BioGaia AB (publ)
BGLAF
$10.24
-$0.18-1.74%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 144.38M | 139.23M | 133.27M | 134.51M | 128.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 144.38M | 139.23M | 133.27M | 134.51M | 128.70M |
| Cost of Revenue | 39.35M | 38.34M | 36.23M | 37.05M | 34.01M |
| Gross Profit | 105.04M | 100.89M | 97.04M | 97.46M | 94.69M |
| SG&A Expenses | 52.90M | 49.65M | 44.94M | 43.87M | 41.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 103.37M | 103.25M | 95.79M | 95.84M | 90.09M |
| Operating Income | 41.01M | 35.98M | 37.48M | 38.67M | 38.61M |
| Income Before Tax | 39.64M | 35.18M | 37.10M | 42.33M | 40.94M |
| Income Tax Expenses | 8.50M | 7.45M | 8.09M | 9.11M | 8.98M |
| Earnings from Continuing Operations | 31.14 | 27.73 | 29.01 | 33.21 | 31.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.14M | 27.73M | 29.01M | 33.21M | 31.96M |
| EBIT | 41.01M | 35.98M | 37.48M | 38.67M | 38.61M |
| EBITDA | 43.55M | 43.41M | 44.83M | 46.00M | 45.93M |
| EPS Basic | 0.31 | 0.27 | 0.29 | 0.33 | 0.32 |
| Normalized Basic EPS | 0.25 | 0.22 | 0.24 | 0.27 | 0.26 |
| EPS Diluted | 0.31 | 0.27 | 0.29 | 0.33 | 0.32 |
| Normalized Diluted EPS | 0.25 | 0.22 | 0.24 | 0.27 | 0.26 |
| Average Basic Shares Outstanding | 404.65M | 404.56M | 404.38M | 404.20M | 404.02M |
| Average Diluted Shares Outstanding | 404.65M | 404.57M | 404.41M | 404.24M | 404.06M |
| Dividend Per Share | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 |
| Payout Ratio | 232.03% | 260.57% | 224.65% | 196.22% | 203.95% |